Journal of Global Antimicrobial Resistance (Jun 2021)
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic
- Jesús Rodríguez-Baño,
- Gian Maria Rossolini,
- Constance Schultsz,
- Evelina Tacconelli,
- Srinivas Murthy,
- Norio Ohmagari,
- Alison Holmes,
- Till Bachmann,
- Herman Goossens,
- Rafael Canton,
- Adam P. Roberts,
- Birgitta Henriques-Normark,
- Cornelius J. Clancy,
- Benedikt Huttner,
- Patriq Fagerstedt,
- Shawon Lahiri,
- Charu Kaushic,
- Steven J. Hoffman,
- Margo Warren,
- Ghada Zoubiane,
- Sabiha Essack,
- Ramanan Laxminarayan,
- Laura Plant
Affiliations
- Jesús Rodríguez-Baño
- Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, Seville, Spain; Departamento de Medicina, Universidad de Sevilla, Seville, Spain; Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain; Red Española de Investigación en Patología Infecciosa (REIPI), Instituto de Salud Carlos III. Madrid, Spain
- Gian Maria Rossolini
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy
- Constance Schultsz
- Department of Global Health–AIGHD Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
- Evelina Tacconelli
- Division of Infectious Diseases, Department of Diagnostic and Public Health, University of Verona, Verona, Italy
- Srinivas Murthy
- BC Children’s Hospital, University of British Columbia, Vancouver, Canada
- Norio Ohmagari
- Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
- Alison Holmes
- Department of Medicine, Faculty of Medicine, Imperial College London, London, UK
- Till Bachmann
- The University of Edinburgh, Edinburgh Medical School, Division of Infection and Pathway Medicine, The Chancellor’s Building, Edinburgh, UK
- Herman Goossens
- Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
- Rafael Canton
- Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain; Red Española de Investigación en Patología Infecciosa (REIPI), Instituto de Salud Carlos III, Madrid, Spain
- Adam P. Roberts
- Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK
- Birgitta Henriques-Normark
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
- Cornelius J. Clancy
- University of Pittsburgh, 3550 Terrace St., Scaife Hall 867, Pittsburgh, PA, USA
- Benedikt Huttner
- Division of Infectious Diseases, Geneva University Hospitals, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- Patriq Fagerstedt
- JPIAMR Secretariat, Swedish Research Council, Stockholm, Sweden
- Shawon Lahiri
- JPIAMR Secretariat, Swedish Research Council, Stockholm, Sweden
- Charu Kaushic
- Institute of Infection and Immunity, Canadian Institutes of Health Research, Canada; McMaster Immunology Research Center, Department Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada
- Steven J. Hoffman
- Global Strategy Lab, Dahdaleh Institute for Global Health Research, School of Global Health and Osgoode Hall Law School, York University, Toronto, Canada
- Margo Warren
- Access to Medicine Foundation, Naritaweg 227-A, 1043 CB, Amsterdam, The Netherlands
- Ghada Zoubiane
- International Centre for Antimicrobial Resistance Solutions (ICARS), Copenhagen, Denmark
- Sabiha Essack
- International Centre for Antimicrobial Resistance Solutions (ICARS), Copenhagen, Denmark; Antimicrobial Research Unit, University of KwaZulu-Natal, Durban, South Africa
- Ramanan Laxminarayan
- Center for Disease Dynamics, Economics & Policy, New Delhi, India
- Laura Plant
- Institute of Infection and Immunity, Canadian Institutes of Health Research, Canada; Corresponding author at: JPIAMR Secretariat, Swedish Research Council, Box 1035, 101 38, Stockholm, Sweden.
- Journal volume & issue
-
Vol. 25
pp. 5 – 7
Abstract
Antimicrobial resistance must be recognised as a global societal priority - even in the face of the worldwide challenge of the COVID-19 pandemic. COVID-19 has illustrated the vulnerability of our healthcare systems in co-managing multiple infectious disease threats as resources for monitoring and detecting, and conducting research on antimicrobial resistance have been compromised during the pandemic. The increased awareness of the importance of infectious diseases, clinical microbiology and infection control and lessons learnt during the COVID-19 pandemic should be exploited to ensure that emergence of future infectious disease threats, including those related to AMR, are minimised. Harnessing the public understanding of the relevance of infectious diseases towards the long-term pandemic of AMR could have major implications for promoting good practices about the control of AMR transmission.
